ABBOTT LABORATORIES (NASDAQ:ABT) Files An 8-K Other Events

Item 8.01. Other Events.

On April26, 2016, Abbott Laboratories (the Company) announced
that it had entered into a definitive Agreement and Plan of
Merger with St. Jude Medical,Inc., a Delaware corporation (St.
Jude Medical), Vault Merger Sub,Inc., a Delaware corporation and
wholly owned subsidiary of the Company, and Vault Merger Sub,
LLC, a Delaware limited liability company and wholly owned
subsidiary of the Company, providing for the acquisition of St.
Jude Medical by the Company.

The consolidated balance sheets of St. Jude Medical and
subsidiaries as of January2, 2016 and January3, 2015 and the
related consolidated statements of earnings, comprehensive
income, shareholders equity and cash flows for the years ended
January2, 2016,January3, 2015 and December28, 2013 and the notes
related thereto contemplated by Rule3-05 of Regulation S-X are
attached hereto as Exhibit99.1 and are incorporated herein by
reference.

The condensed consolidated balance sheets of St. Jude Medical and
subsidiaries as of October1, 2016 and January2, 2016, and the
related condensed consolidated statements of earnings,
comprehensive income and cash flows for the nine months ended
October1, 2016 and October3, 2015 and the notes related thereto
contemplated by Rule3-05 of Regulation S-X are attached hereto as
Exhibit99.2 and are incorporated here in by reference.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits.

About ABBOTT LABORATORIES (NASDAQ:ABT)